Metastatic pancreatic cancer: Another option.

Shrikhande, Shailesh V; Gupta, Sudeep; Ostwal, Vikas

Shrikhande, Shailesh V; Gupta, Sudeep; Ostwal, Vikas.

Article in En | IMSEAR | ID: sea-139243

Subject(s)

Antimetabolites, Antineoplastic/adverse effects; Antimetabolites, Antineoplastic/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Deoxycytidine/analogs & derivatives; Deoxycytidine/therapeutic use; Female; Fluorouracil/administration & dosage; Follow-Up Studies; Humans; Leucovorin/administration & dosage; Male; Neoplasm Metastasis/drug therapy; Pancreatic Neoplasms/drug therapy; Pancreatic Neoplasms/mortality; Pancreatic Neoplasms/pathology; Proportional Hazards Models; Quality of Life; Severity of Illness Index; Survival Analysis

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Pancreatic Neoplasms / Quality of Life / Severity of Illness Index / Female / Humans / Male / Camptothecin / Antineoplastic Combined Chemotherapy Protocols / Proportional Hazards Models / Survival Analysis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

Search on Google